David Mountcastle - 05 Jul 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: EVP & Chief Financial Officer
Signature: /s/ Thomas Bartrum, as attorney-in fact
Issuer symbol: PRVA
Transactions as of: 05 Jul 2022
Net transactions value: -$813,140
Form type: 4
Filing time: 07 Jul 2022, 18:28:56 UTC
Previous filing: 30 Jun 2022
Next filing: 08 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$38,560	+19,280	+24%	$2.00^*	100,384	05 Jul 2022	Direct
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$538,475	-17,580	-18%	$30.63	82,804	05 Jul 2022	Direct	F1, F2
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$34,485	-1,100	-1.3%	$31.35	81,704	05 Jul 2022	Direct	F1, F3
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$16,105	-500	-0.61%	$32.21	81,204	05 Jul 2022	Direct	F1, F4
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$3,342	-100	-0.12%	$33.42	81,104	05 Jul 2022	Direct	F1
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$40,000	+20,000	+25%	$2.00^*	101,104	06 Jul 2022	Direct
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$298,982	-9,723	-9.6%	$30.75	91,381	06 Jul 2022	Direct	F1
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	$311	-10	-0.01%	$31.06	91,371	06 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-19,280	-52%	$0.000000	17,861	05 Jul 2022	Common Stock	19,280	$2.00	Direct	F5
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-20,000	-48%	$0.000000	21,666	06 Jul 2022	Common Stock	20,000	$2.00	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.97 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.03 to $31.97 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.08 to $32.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5	Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 28,210 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022 and 2,493 of the stock options will vest December 4, 2022.
F6	Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 26,666 of the stock options are fully vested and exercisable. 4,167 of the stock options will vest on September 8, 2022, 6,667 of the stock options vest on October 29, 2022 and 4,166 of the stock options will vest on September 8, 2023.